View Document Preview and Link Document Date: 2013-01-17 23:37:12 Open Document File Size: 302,42 KB Share Result on Facebook
City MOUNTAIN VIEW / / Company BCC Partners / TheraVida Inc. / / Country Australia / South Korea / New Zealand / / / Event FDA Phase / Patent Filing / / IndustryTerm patent-protected combination drug technology / clinical-stage biopharmaceutical company developing novel combination drug products / combination drug products / combination drug technology / / MedicalCondition Overactive Bladder / disease / urinary incontinence / diabetes / common disorder / xerostomia / asthma / / Person Michelle Corral / Roger Flugel / Karen L. Bergman / / / Position CEO / Chief Executive Officer / / Product tolterodine / Detrol / Tolenix / Tolenix™ / Tolenix ™ / / ProvinceOrState California / / Technology combination drug technology / patent-protected combination drug technology / / URL www.theravida.com / / SocialTag 
TM MAKING LIFE BETTER, EVERY DAY TheraVida Announces Positive Top-Line Phase 2 Results for Tolenix™ (THVD-201) in Patients with Overactive Bladder and Urge Urinary Incontinence